Related Experiment Video
Updated: Nov 13, 2025
06:28
Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization
Published on: June 4, 2020
7.0K
Peripartum Management in Myelodysplastic Syndrome Guided by Serial Thromboelastography: A Case Report
Arunthevaraja Karuppiah1, Jessica L Galey1, Shobana Bharadwaj1
1From the Departments of Anesthesiology.
A&A Practice
|March 12, 2021
Summary
Managing myelodysplastic syndrome with severe thrombocytopenia in childbearing women requires careful coagulation control. Thromboelastography can guide minimal platelet transfusions, preventing allo-sensitization and preserving future bone marrow transplant options.
Area of Science:
- Hematology
- Obstetrics
- Transfusion Medicine
Background:
- Myelodysplastic syndromes (MDS) are a group of clonal hematopoietic stem cell disorders.
- Severe thrombocytopenia in women of childbearing age presents unique management challenges, particularly during pregnancy.
- Maintaining adequate hemostasis while minimizing platelet transfusions is critical to avoid allo-sensitization.
Observation:
- The peripartum period poses significant risks for patients with severe thrombocytopenia due to potential bleeding complications.
- Repeated platelet transfusions can lead to allo-immunization, complicating future medical interventions.
- Allo-sensitization poses a risk for future lifesaving procedures like bone marrow transplantation.
Findings:
- Thromboelastography (TEG) is a valuable point-of-care viscoelastic hemostasis assay.
- TEG can accurately assess coagulation status and guide transfusion strategies in real-time.
- Utilizing TEG can help optimize platelet transfusion requirements, reducing unnecessary transfusions.
Implications:
- Implementing thromboelastography can lead to more precise management of thrombocytopenia in pregnant patients.
- Minimizing allogeneic platelet exposure preserves the potential for successful bone marrow transplantation.
- This approach enhances patient safety and long-term treatment options for women with MDS.
Related Concept Videos
01:30Venous Thrombosis IV: Nursing Management
80
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
80
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
108
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
108
01:29Venous Thrombosis III: Interprofessional Care
103
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
103
01:27Pulmonary Embolism III: Nursing Management
121
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
121
01:22Mitral Valve Prolapse II: Assessment and Management
150
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
150
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
110
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
110